基于CiteSpace分析2015年-2019年经内镜逆行胰胆管造影研究领域的热点及趋势

程丽霞; 沈小春; 兰春慧; 陈东风; 周银斌; 王涛

doi:10.3969/j.issn.1001-5256.2020.08.024

基于CiteSpace分析2015年-2019年经内镜逆行胰胆管造影研究领域的热点及趋势

DOI: 10.3969/j.issn.1001-5256.2020.08.024

1. 陆军军医大学大坪医院医研部
2. 陆军军医大学大坪医院消化内科

基金项目:

陆军军医大学临床医学科研人才培养计划(2018XLC3059)；国家自然科学基金面上项目(81972305)；

详细信息

中图分类号: R576;R575
计量
- 文章访问数: 1238
- HTML全文浏览量: 33
- PDF下载量: 160
- 被引次数: 0
出版历程
- 出版日期: 2020-08-20

Research hotspots and trends in endoscopic retrograde cholangiopancreatography in 2015-2019 based on CiteSpace

Daping Hospital, Army Medical University

Research funding:

摘要

摘要:
目的经内镜逆行胰胆管造影（ERCP）是微创治疗胆胰系统疾病的重要手段。通过对全球ERCP领域发表的相关文献进行分析,以期把握该领域的研究现状、热点及发展趋势。方法选取Web of Science平台的web of science core collection数据库,采用主题词"TS=（Cholangiopancreatography,Endoscopic Retrograde）"进行检索,检索时间范围为2015年1月1日-2019年12月31日,并将文献类型选择为"article";随后使用CiteSpace5.6.R2 （64-bit）文献计量分析软件对作者、关键词、发文机构、国家（地区）、参考文献等进行分析并绘制可视化图谱。结果共纳入1535篇ERCP研究领域文献。分析结果显示,Hiroyuki Isayama、Yousuke Nakai、Takeshi Ogura等作者发文最多;东京大学、上海交通大学、蔚山大学医学院等机构发文数量最多。美国、日本、中国等是近5年发文最多的国家。ERCP、并发症、危险因素等是近5年出现频次最高的关键词。共被引频次最高的文献主要集中于ERCP并发症...
- 胰胆管造影术,内窥镜逆行 /
- 文献计量学 /
- CiteSpace
Abstract:
Objective To analyze the articles on endoscopic retrograde cholangiopancreatography(ERCP),an important method for minimally invasive treatment of biliary and pancreatic diseases,published worldwide,and to investigate the status,hotspots,and development trends in this field.Methods The web of science core collection database in Web of Science platform was selected to search by the subject words“TS=(Cholangiopancreatography,Endoscopic Retrograde) ”,for the articles published from January 1,2015 to December 31,2019,and the literature type was selected as“article”.CiteSpace 5.6.R2(64-bit) was used to analyze the authors,key words,institutions,countries(regions),and references and plot visualized maps.Results A total of 1535 articles on ERCP were included.The analysis showed that Hiroyuki Isayama had the highest number of published articles,followed by Yousuke Nakai and Takeshi Ogura,and University of Tokyo had the highest number of published articles,followed by Shanghai Jiao Tong University and University of Ulsan College of Medicine.Moreover,the US,Japan,and China were the top three countries from the aspect of the number of published articles in the recent 5 years,and ERCP,complication,and risk factor were the key words with the highest frequency in the recent 5 years.The most frequently cited articles mainly focused on the complications of ERCP and related consensus or guidelines.Conclusion The main research hotspots and trends in the field of ERCP are related factors and clinical prevention of ERCP-related complications.
- cholangiopancreatography,endoscopic retrograde /
- bibliometrics /
- CiteSpace

HTML全文

参考文献(40)

[1] BONZI M,FIORELLI EM,Gruppo di Autoformazione Metodologica(Gr AM). Indomethacin prevents post-ERCP pancreatitis in selected high-risk patients[J]. Intern Emerg Med,2012,7(6):557-558.

[2] FRANK CD,ADLER DG. Post-ERCP pancreatitis and its prevention[J]. Nat Clin Pract Gastroenterol Hepatol,2006,3(12):680-688.

[3] DUMONCEAU JM,KAPRAL C,AABAKKEN L,et al. ERCPrelated adverse events:European Society of Gastrointestinal Endoscopy(ESGE)Guideline[J]. Endoscopy,2020,52(2):127-149.

[4] BAI Y,LI F,WANG SL,et al. Chinese expert consensus on perioperative medications for endoscopic retrograde cholangiopancreatography(ERCP)[J]. J Dig Dis,2019,20(3):103-113.

[5] PEKGZ M. Post-endoscopic retrograde cholangiopancreatography pancreatitis:A systematic review for prevention and treatment[J]. World J Gastroenterol,2019,25(29):4019-4042.

[6] MENG W,LEUNG JW,ZHANG K,et al. Optimal dilation time for combined small endoscopic sphincterotomy and balloon dilation for common bile duct stones:A multicentre,singleblinded,randomised controlled trial[J]. Lancet Gastroenterol Hepatol,2019,4(6):425-434.

[7] LIU ZY,CHEN CM,HOU HY,et al. Towards an epoch of great changes of science studies[J]. Sci Sci Manag S T,2009,30(7):5-12.(in Chinese)刘则渊，陈超美，侯海燕，等．迈向科学学大变革的时代[J]．科学学与科学技术管理，2009,30(7):5-12.

[8] SHI JY,WU T,YANG J,et al. Mapping knowledge domains analysis of transfusion medicine research based on Cite SpaceⅢ[J]. J Mod Lab Med,2015,30(3):24-27,31.(in Chinese)史纪元，吴涛，杨筠，等．基于Cite SpaceⅢ输血医学研究领域知识图谱分析[J]．现代检验医学杂志，2015,30(3):24-27,31.

[9] CHEN C. Cite Space II:Detecting and visualizing emerging trends and transient patterns in scientific literature[J]. J Am Soc Inf Sci Tec,2006,57(3):359-377.

[10] Derek John de Solla Price. Little Science,Big Science[M].Translated by Song Jiangeng,Dai Zhenfei. Beijing:International Science Organization,1982:39-42.(in Chinese)D．普赖斯．小科学，大科学[M]．宋剑耕，戴振飞，译．北京:世界科学社，1982:39-42.

[11] WANG SB,CHEN ZJ,CHENG YJ,et al. Mapping knowledge domain analasis on treatment of type 2 diabetes mellitus by traditional Chinese medicine[J]. Chin Arch Tradit Chin Med,2016,34(9):2082-2087.(in Chinese)王淑斌，陈子杰，程玉娟，等．中医药治疗2型糖尿病知识图谱分析[J]．中华中医药学刊，2016,34(9):2082-2087.

[12] QIU JP,ZHANG XP. Author co-citation analysis of knowledge management in China based on the CSSCI[J]. Inf Sci,2011,29(10):1441-1445.(in Chinese)邱均平，张晓培．基于CSSCI的国内知识管理领域作者共被引分析[J]．情报科学，2011,29(10):1441-1445.

[13] ZHANG XT. Analysis on the research hotspots of nationwide reading through the SNA[J]. J Lib Inf Sci Agric,2016,28(6):80-84.(in Chinese)章小童．基于社会网络分析法的全民阅读研究热点探析[J]．农业图书情报学刊，2016,28(6):80-84.

[14] ELMUNZER BJ,SCHEIMAN JM,LEHMAN GA,et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis[J]. N Engl J Med,2012,366(15):1414-1422.

[15] DUMONCEAU JM,ANDRIULLI A,ELMUNZER BJ,et al. Prophylaxis of post-ERCP pancreatitis:European Society of Gastrointestinal Endoscopy(ESGE)Guideline-updated June 2014[J].Endoscopy,2014,46(9):799-815.

[16] ANDERSON MA,FISHER L,JAIN R,et al. Complications of ERCP[J]. Gastrointest Endosc,2012,75(3):467-473.

[17] COTTON PB,EISEN GM,AABAKKEN L,et al. A lexicon for endoscopic adverse events:Report of an ASGE workshop[J]. Gastrointest Endosc,2010,71(3):446-454.

[18] BANKS PA,BOLLEN TL,DERVENIS C,et al. Classification of acute pancreatitis—2012:Revision of the Atlanta classification and definitions by international consensus[J]. Gut,2013,62(1):102-111.

[19] COTTON PB,GARROW DA,GALLAGHER J,et al. Risk factors for complications after ERCP:A multivariate analysis of11,497 procedures over 12 years[J]. Gastrointest Endosc,2009,70(1):80-88.

[20] Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis[J]. Pancreatology,2013,13(4 Suppl 2):e1-e15.

[21] TESTONI PA,MARIANI A,GIUSSANI A,et al. Risk factors for post-ERCP pancreatitis in high-and low-volume centers and among expert and non-expert operators:A prospective multicenter study[J]. Am J Gastroenterol,2010,105(8):1753-1761.

[22] ASGE Standards of Practice Committee,MAPLE JT,BENMENACHEM T,et al. The role of endoscopy in the evaluation of suspected choledocholithiasis[J]. Gastrointest Endosc,2010,71(1):1-9.

[23] CHOUDHARY A,BECHTOLD ML,ARIF M,et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis:A meta-analysis and systematic review[J]. Gastrointest Endosc,2011,73(2):275-282.

[24] KHOSHBATEN M,KHORRAM H,MADAD L,et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. J Gastroenterol Hepatol,2008,23(7 Pt 2):e11-e16.

[25] ELMUNZER BJ,WALJEE AK,ELTA GH,et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis[J]. Gut,2008,57(9):1262-1267.

[26] AKSHINTALA VS,HUTFLESS SM,COLANTUONI E,et al.Systematic review with network meta-analysis:Pharmacological prophylaxis against post-ERCP pancreatitis[J]. Aliment Pharmacol Ther,2013,38(11-12):1325-1337.

[27] ELMUNZER BJ,HIGGINS PD,SAINI SD,et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data[J]. Am J Gastroenterol,2013,108(3):410-415.

[28] LUO H,ZHAO L,LEUNG J,et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography:A multicentre,single-blinded, randomised controlled trial[J]. Lancet,2016,387(10035):2293-2301.

[29] LEVENICK JM,GORDON SR,FADDEN LL,et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients[J]. Gastroenterology,2016,150(4):911-917.

[30] MENES T,SPIVAK H. Laparoscopy:Searching for the proper insufflation gas[J]. Surg Endosc,2000,14(11):1050-1056.

[31] COSTAMAGNA G,SHAH SK,TRINGALI A. Current management of postoperative complications and benign biliary strictures[J].Gastrointest Endosc Clin N Am,2003,13(4):635-648.

[32] JIMNEZ-ROMERO C,MANRIQUE A,GARCA-CONDE M,et al. Biliary complications after liver transplantation from uncontrolled donors after circulatory death:Incidence,management,and outcome[J]. Liver Transpl,2020,26(1):80-91.

[33] WANG Q,MOON SB,ZANG J,et al. Usefulness of pre-operative endoscopic retrograde cholangiopancreatography in diagnosis and management of forme fruste choledochal cyst in children[J]. ANZ J Surg,2020.[Online ahead of print]

[34] FURUKAWA K,ONDA S,HAMURA R,et al. Predictive factors and surgical outcomes of stent dysfunction after preoperative endoscopic biliary stenting in patients who underwent pancreaticoduodenectomy[J]. J Laparoendosc Adv Surg Tech A,2020,30(3):256-259.

[35] CHENG LL,TANG CF,ZHAO JH,et al. Recent advances in digestive endoscopy in the field of pancreaticobiliary diseases[J]. J Clin Hepatol,2019,35(1):222-225.(in Chinese)程里礼，唐超峰，赵继航，等．消化内镜技术在胆胰领域的应用现状[J]．临床肝胆病杂志，2019,35(1):222-225.

[36] ZHOU HX,DONG XY,BU P,et al. Application of endoscopic retrograde cholangiopancreatography in treatment of extrahepatic biliary adenoma[J]. J Clin Hepatol,2016,32(12):2353-2355.(in Chinese)周海祥，董小耘，卜平，等．经内镜逆行胰胆管造影在肝外胆管腺瘤诊治中的应用[J]．临床肝胆病杂志，2016,32(12):2353-2355.

[37] WANG ZC. Curative effect of ERCP on senile patients with choledocholithiasis and its effect on serum inflammatory factors[J]. Trauma and Crit Medicine,2019,7(4):233-235.(in Chinese)王智超．内镜下逆行胆胰管造影术对老年胆总管结石患者疗效研究[J]．创伤与急危重病医学，2019,7(4):233-235.

[38] GUO XG. Reconsideration and thoughts of endoscopic retrograde cholangiopancreatography in China[J]. Chin J Dig Endosc,2016,33(5):273-276.(in Chinese)郭学刚．中国ERCP再认识和思考[J]．中华消化内镜杂志，2016,33(5):273-276.

[39] COLTON JB,CURRAN CC. Quality indicators,including complications,of ERCP in a community setting:A prospective study[J]. Gastrointest Endosc,2009,70(3):457-467.

[40] WILLIAMS EJ,TAYLOR S,FAIRCLOUGH P,et al. Risk factors for complication following ERCP; results of a largescale,prospective multicenter study[J]. Endoscopy,2007,39(9):793-801.

施引文献

资源附件(0)

访问统计